Health-related quality of life among people living with HIV in the era of universal test and treat: results from a cross-sectional study in KwaZulu-Natal, South Africa.

IF 1.7 4区 医学 Q3 INFECTIOUS DISEASES HIV Research & Clinical Practice Pub Date : 2023-12-21 Epub Date: 2024-01-13
Reuben Christopher Moyo, Lovemore N Sigwadhi, Stanley Carries, Zibuyisile Mkhwanazi, Arvin Bhana, Davide Bruno, Eugene L Davids, Marie-Claire Van Hout, Darshini Govindasamy
{"title":"Health-related quality of life among people living with HIV in the era of universal test and treat: results from a cross-sectional study in KwaZulu-Natal, South Africa.","authors":"Reuben Christopher Moyo, Lovemore N Sigwadhi, Stanley Carries, Zibuyisile Mkhwanazi, Arvin Bhana, Davide Bruno, Eugene L Davids, Marie-Claire Van Hout, Darshini Govindasamy","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The World Health Organisation's (WHO) key population-based strategy for ending the human immunodeficiency virus (HIV) epidemic is universal HIV test and treat (UTT) along with pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP). Despite the successful scale-up of the UTT strategy in sub-Saharan Africa (SSA), the quality of life (QoL) of people living with HIV (PLHIV) remains sub-optimal. Poor QoL in PLHIV may threaten the UNAIDS 95-95-95 programme targets. Monitoring QoL of PLHIV has become a key focus of HIV research among other outcomes so as to understand health-related QoL (HRQoL) profiles and identify interventions to improve programme performance. This study aimed to describe HRQoL profiles and identify their predictors in PLHIV in KwaZulu Natal, South Africa.</p><p><strong>Methods: </strong>We conducted a secondary data analysis of a cross-sectional survey conducted between May and June 2022 among PLHIV (<i>n</i> = 105) accessing HIV services at an outpatient clinic in KwaZulu-Natal, South Africa. Socio-demographic, HRQoL (EQ-5D-5L index scores), clinical data, depressive symptoms (CES-D-10), and viral load data were collected from all participants. We examined predictors of HRQoL using generalised linear models controlling for age and sex.</p><p><strong>Results: </strong>The mean age of the participants was 45 years (SD = 13). The proportion of participants with disabilities and comorbidities were 3% and 18%, respectively. Depressive symptoms were present in 49% of the participants. Participant's mean EQ-5D-5L index score was 0.87 (SD = 0.21) and ranged from 0.11 to 1.0. The mean general health state (EQ-VAS) was 74.7 (SD = 18.8) and ranged from 6 to 100. Factors that reduced HRQoL were disability (β = -0.607, <i>p</i> ≤ 0.001), comorbidities (β = - 0.23, <i>p</i> ≤ 0.05), presence of depressive symptoms (β = -0.10, <i>p</i> ≤ 0.05), and old age (β = -0.04, <i>p</i> ≤ 0.05). Factors that increased HRQoL were a good perceived health state (β = 0.147, <i>p</i> ≤ 0.001) and availability of social support (β = 0.098, <i>p</i> ≤ 0.05).</p><p><strong>Conclusion: </strong>A combination of old age (60 years and above), any disability and comorbidities had a considerable effect on HRQoL among PLHIV. Our findings support the recommendation for an additional fourth UNAIDS target that should focus on ensuring that 95% of PLHIV have the highest possible HRQoL. Psycho-social support interventions are recommended to improve the HRQoL of PLHIV.</p>","PeriodicalId":13165,"journal":{"name":"HIV Research & Clinical Practice","volume":"25 1","pages":"2298094"},"PeriodicalIF":1.7000,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Research & Clinical Practice","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The World Health Organisation's (WHO) key population-based strategy for ending the human immunodeficiency virus (HIV) epidemic is universal HIV test and treat (UTT) along with pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP). Despite the successful scale-up of the UTT strategy in sub-Saharan Africa (SSA), the quality of life (QoL) of people living with HIV (PLHIV) remains sub-optimal. Poor QoL in PLHIV may threaten the UNAIDS 95-95-95 programme targets. Monitoring QoL of PLHIV has become a key focus of HIV research among other outcomes so as to understand health-related QoL (HRQoL) profiles and identify interventions to improve programme performance. This study aimed to describe HRQoL profiles and identify their predictors in PLHIV in KwaZulu Natal, South Africa.

Methods: We conducted a secondary data analysis of a cross-sectional survey conducted between May and June 2022 among PLHIV (n = 105) accessing HIV services at an outpatient clinic in KwaZulu-Natal, South Africa. Socio-demographic, HRQoL (EQ-5D-5L index scores), clinical data, depressive symptoms (CES-D-10), and viral load data were collected from all participants. We examined predictors of HRQoL using generalised linear models controlling for age and sex.

Results: The mean age of the participants was 45 years (SD = 13). The proportion of participants with disabilities and comorbidities were 3% and 18%, respectively. Depressive symptoms were present in 49% of the participants. Participant's mean EQ-5D-5L index score was 0.87 (SD = 0.21) and ranged from 0.11 to 1.0. The mean general health state (EQ-VAS) was 74.7 (SD = 18.8) and ranged from 6 to 100. Factors that reduced HRQoL were disability (β = -0.607, p ≤ 0.001), comorbidities (β = - 0.23, p ≤ 0.05), presence of depressive symptoms (β = -0.10, p ≤ 0.05), and old age (β = -0.04, p ≤ 0.05). Factors that increased HRQoL were a good perceived health state (β = 0.147, p ≤ 0.001) and availability of social support (β = 0.098, p ≤ 0.05).

Conclusion: A combination of old age (60 years and above), any disability and comorbidities had a considerable effect on HRQoL among PLHIV. Our findings support the recommendation for an additional fourth UNAIDS target that should focus on ensuring that 95% of PLHIV have the highest possible HRQoL. Psycho-social support interventions are recommended to improve the HRQoL of PLHIV.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
普遍检测和治疗时代艾滋病毒感染者与健康相关的生活质量:南非夸祖鲁-纳塔尔省横断面研究结果。
背景:世界卫生组织(WHO)结束人类免疫缺陷病毒(HIV)流行的主要人口战略是普及 HIV 检测和治疗(UTT)以及暴露前预防(PrEP)和暴露后预防(PEP)。尽管在撒哈拉以南非洲地区(SSA)成功推广了 UTT 战略,但艾滋病毒感染者(PLHIV)的生活质量(QoL)仍未达到最佳水平。艾滋病毒感染者(PLHIV)的生活质量低下可能会威胁到联合国艾滋病规划署(UNAIDS)95-95-95 计划目标的实现。监测艾滋病毒感染者的 QoL 已成为艾滋病研究的重点之一,以便了解与健康相关的 QoL(HRQoL)概况,并确定干预措施以提高计划绩效。本研究旨在描述南非夸祖鲁-纳塔尔省艾滋病毒感染者的 HRQoL 状况,并确定其预测因素:我们对 2022 年 5 月至 6 月期间在南非夸祖鲁-纳塔尔省一家门诊诊所接受 HIV 服务的 PLHIV(n = 105)进行的横断面调查进行了二次数据分析。我们收集了所有参与者的社会人口学、HRQoL(EQ-5D-5L 指数得分)、临床数据、抑郁症状(CES-D-10)和病毒载量数据。我们使用控制年龄和性别的广义线性模型研究了预测 HRQoL 的因素:结果:参与者的平均年龄为 45 岁(SD = 13)。有残疾和合并症的参与者比例分别为 3% 和 18%。49%的参与者有抑郁症状。参与者的平均 EQ-5D-5L 指数得分为 0.87(SD = 0.21),范围在 0.11 至 1.0 之间。一般健康状况(EQ-VAS)的平均值为 74.7(标准差 = 18.8),范围在 6 到 100 之间。降低 HRQoL 的因素包括残疾(β = -0.607,p ≤ 0.001)、合并症(β = -0.23,p ≤ 0.05)、抑郁症状(β = -0.10,p ≤ 0.05)和年龄(β = -0.04,p ≤ 0.05)。增加 HRQoL 的因素是良好的健康感知状态(β = 0.147,p ≤ 0.001)和社会支持的可获得性(β = 0.098,p ≤ 0.05):高龄(60 岁及以上)、任何残疾和合并症对艾滋病毒感染者的 HRQoL 有相当大的影响。我们的研究结果支持联合国艾滋病规划署关于增加第四个目标的建议,即重点确保 95% 的艾滋病毒感染者拥有尽可能高的 HRQoL。建议采取社会心理支持干预措施,以改善艾滋病毒感染者的 HRQoL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.90
自引率
6.20%
发文量
15
期刊最新文献
A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago. Evaluation of the effect of 48 weeks of BIC/F/TAF and DRV/c/F/TAF on platelet function in the context of rapid ART start. 'It is scary to pause treatment': perspectives on HIV cure-related research and analytical treatment interruptions from women diagnosed during acute HIV in Durban, South Africa. Impacts of a multipronged initiative with community HIV clinics to support retention and re-engagement in HIV care. Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1